FDA Clears AI for Heart Procedure Planning
DASI Simulations' AI gains FDA clearance, aiding TAVR planning and boosting cardiology's role in healthcare AI.
- Latest
- Trending
DASI Simulations' AI gains FDA clearance, aiding TAVR planning and boosting cardiology's role in healthcare AI.
Moderna shares dip as R&D spending reduces, focusing on FDA approval for 10 key products including RSV and cancer treatments.
Eli Lilly launches affordable Zepbound vials, easing supply issues and competing with Novo Nordisk's weight-loss drug.
Exploring innovative ways to convert plastic waste into food using microbes, offering sustainable solutions to global waste issues.
Revolutionary solvent-based method removes 98% of nanoplastics from water, promising cleaner oceans and safer ecosystems.
FDA plans to clear numerous AI algorithms, enhancing healthcare through advanced technology regulation and streamlined processes.
Fortress Biotech reveals Q2 2024 financials with key FDA updates; NDA and BLA filings signal growth in dermatology and oncology.
PDS Biotech aligns with FDA for Phase 3 trial, reports Q2 2024 financials with reduced net loss and expenses.
Interlynk to provide SBOM generation, vulnerability reporting, and risk assessment for BIOTRONIK's life-saving products.
22nd Century Group cuts debt by $1.5M, aiming for financial stability and progress in tobacco harm reduction using advanced technology.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.